Published

Psilocybin alters the circulating metabolomic profile in both non-clinical and clinical models

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Brain Behavior and Immunity
Date: 2024-11-01
Source: OpenAlex
DOI: 10.1016/j.bbi.2024.12.146
PubMed: Unavailable

Authors

Emese Prandovszky O’Donnell Zachary A. Cordner Hua Liu Shuojia Yang Lindsey Macias Kellie L. Tamashiro Frederick S. Barrett Robert H. Yolken

Watch author

Derived topics and classifications

psilocybin Pharmacology Metabolomics Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin alters the circulating metabolomic profile in both non-clinical and clinical models2024-11-01

Related papers

Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test?Journal of Humanistic Psychology · 2022-08-18 A-118 Psychedelic Interventions for Neuropsychological ConditionsArchives of Clinical Neuropsychology · 2022-08-16 Developing Guidelines and Competencies for the Training of Psychedelic TherapistsJournal of Humanistic Psychology · 2017-06-29 Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of AlcoholismJournal of Humanistic Psychology · 2016-10-16 Psychedelic Psychotherapy: Insights From 25 Years of ResearchJournal of Humanistic Psychology · 2016-09-29 Current U.S. Approaches to Studying Psychedelic Medicines Compared to Psychedelics Use Among Indigenous Groups: What Are We Missing?Journal of Humanistic Psychology · 2025-03-21 The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic ReviewJournal of Sociology Psychology & Religious Studies · 2023-11-06 Psychedelic Drug Therapy for Mental Disorders?Open Journal of Medical Psychology · 2023-01-01